This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 25/7/1347    most recent 01.ATV.0000167520.41436.c0v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Duftner, C. Articles by Schirmer, M. Search for Related Content PubMed PubMed Citation Articles by Duftner, C. Articles by Schirmer, M. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Aortic Aneurysm

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1347.)
© 2005 American Heart Association, Inc.

Vascular Biology

High Prevalence of Circulating CD4⁺CD28^– T-Cells in Patients With Small Abdominal Aortic Aneurysms

Christina Duftner; Rüdiger Seiler; Peter Klein-Weigel; Heike Göbel; Christian Goldberger; Christian Ihling; Gustav Fraedrich; Michael Schirmer

From the Departments of Internal Medicine (C.D., C.G., M.S.) and Vascular Surgery (R.S., P.K.-W., G.F.), Innsbruck Medical University, Innsbruck, Austria; and the Department of Pathology (H.G., C.I.), University Hospital, Freiburg, Germany.

Correspondence to Michael Schirmer, MD, Assoc Prof, Clinical Department of Internal Medicine, Clinical Division of General Internal Medicine, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria. E-mail michael.schirmer{at}uibk.ac.at

Objective— To assess the possible role of proinflammatory CD28^– T cells in abdominal aortic aneurysms (AAAs). Animal studies and human tissue studies suggest a role for interferon (IFN)-–producing T cells in the development and progression of AAAs.

Methods and Results— Fluorescence-activated cells sorter analysis of peripheral blood samples and measurement of AAA size using sonography were performed in 101 AAA patients and 38 healthy controls. Peripheral percentages of CD28^– T cells of the CD3⁺CD4⁺ and the CD3⁺CD8⁺ were enriched in AAA patients with 7.8±8.8% and 41.9±15.7% compared with healthy controls with 2.2±6.1% and 24.9±15.5%, respectively (P=0.002 and P<0.001, respectively). Both CD4⁺CD28^– and CD8⁺CD28^– T cells produced large amounts of IFN- and perforin. Patients with small AAAs (<4 cm) showed higher peripheral levels of CD4⁺CD28^– T cells than those with larger AAAs (P=0.025). Immunohistological examinations revealed 39.1±17.2% CD4⁺CD28^– and 44.0±13.8% CD8⁺CD28^– in AAA tissue specimens with inflammatory infiltrates.

Conclusions— IFN-– and perforin-producing CD28^– T cells are present in the periphery and the vessel wall of a majority of AAAs. This observation in humans favors the concept of a T cell–mediated pathophysiology of AAAs, especially during the early development of AAAs.

Animal studies and tissue studies suggest a role for interferon (IFN)-–producing T cells in the development of abdominal aortic aneurysms (AAAs). This study shows an increased prevalence of circulating IFN-–producing CD28^– T cells especially in smaller AAAs, and thus supports the concept of a T cell–mediated pathophysiology of AAAs.

Key Words: aortic disease • aneurysms • leukocytes • immune system • human

This article has been cited by other articles:

				A. E. R. Fasth, M. Dastmalchi, A. Rahbar, S. Salomonsson, J. M. Pandya, E. Lindroos, I. Nennesmo, K.-J. Malmberg, C. Soderberg-Naucler, C. Trollmo, et al. T Cell Infiltrates in the Muscles of Patients with Dermatomyositis and Polymyositis Are Dominated by CD28null T Cells J. Immunol., October 1, 2009; 183(7): 4792 - 4799. [Abstract] [Full Text] [PDF]

				J. H.N. Lindeman, H. Abdul-Hussien, J. H. van Bockel, R. Wolterbeek, and R. Kleemann Clinical Trial of Doxycycline for Matrix Metalloproteinase-9 Inhibition in Patients With an Abdominal Aneurysm: Doxycycline Selectively Depletes Aortic Wall Neutrophils and Cytotoxic T Cells Circulation, April 28, 2009; 119(16): 2209 - 2216. [Abstract] [Full Text] [PDF]

				S Stojanov, C Dejaco, P Lohse, K Huss, C Duftner, B H Belohradsky, M Herold, and M Schirmer Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment Ann Rheum Dis, September 1, 2008; 67(9): 1292 - 1298. [Abstract] [Full Text] [PDF]

				H. Kuivaniemi, C. D. Platsoucas, and M. D. Tilson III Aortic Aneurysms: An Immune Disease With a Strong Genetic Component Circulation, January 15, 2008; 117(2): 242 - 252. [Full Text] [PDF]

				G. Caligiuri, P. Rossignol, P. Julia, E. Groyer, D. Mouradian, D. Urbain, N. Misra, V. Ollivier, M. Sapoval, P. Boutouyrie, et al. Reduced Immunoregulatory CD31+ T Cells in Patients With Atherosclerotic Abdominal Aortic Aneurysm Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 618 - 623. [Abstract] [Full Text] [PDF]

				C. Galle, L. Schandene, J.-P. Dereume, M. Goldman, C. Duftner, C. Dejaco, and M. Schirmer CD8+ T-Cell Subpopulations in Human Abdominal Aortic Aneurysm Lesion Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): e19 - e20. [Full Text] [PDF]